[1]
L. Zaripova, “Biological Therapy for Osteoarthritis, Efficacy and Safety: Focus on Monoclonal Antibodies against Nerve Growth Factor and Fibroblast Growth Factor-18”, Open Access Maced J Med Sci, vol. 10, no. F, pp. 697–704, Sep. 2022.